Department of Metabolism and Endocrinology, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
Sportology Center, Graduate School of Medicine, Juntendo University, Tokyo, Japan.
J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2835-2842. doi: 10.1002/jcsm.13074. Epub 2022 Sep 2.
Sarcopenia is a major cause of disability in the elderly. Although type 2 diabetes is a risk factor for increased sarcopenia, the relationship between prediabetes and sarcopenia has not been elucidated. We aimed to examine the relationship between sarcopenia and prediabetes.
The design of this study is a cross-sectional study. We evaluated glucose metabolism using the 75-g oral glucose tolerance test and glycated haemoglobin, appendicular skeletal muscle mass, and hand grip strength in 1629 older adults living in an urban area of Tokyo, Japan. We investigated the frequency of sarcopenia in participants with normal glucose tolerance (NGT), prediabetes and diabetes. A multivariable logistic regression model was used to analyse the association between glucose tolerance and the prevalence of sarcopenia.
The mean age of participants was 73.1 ± 5.4 years. In men, 44.3% had NGT, 26.6% had prediabetes, and 29.1% had diabetes. In women, the distribution was 56.1%, 28.8% and 15.2%. The prevalence of sarcopenia was 12.7% in men and 11.9% in women. Logistic regression revealed that prediabetes and diabetes are independent risk factors for sarcopenia in men (prediabetes, odds ratio [OR] = 2.081 [95% confidence interval {CI}: 1.031-4.199]; diabetes, OR = 2.614 [95% CI: 1.362-5.018]) and diabetes, but not prediabetes, is an independent risk factor for sarcopenia in women (prediabetes, OR = 1.036 [95% CI: 0.611-1.757]; diabetes, OR = 2.099 [95% CI: 1.146-3.844]). In both sexes, higher age (men, OR = 1.086 [95% CI: 1.028-1.146]; women, OR = 1.195 [95% CI: 1.142-1.251]), higher body fat percentage (men, OR = 1.346 [95% CI: 1.240-1.461]; women, OR = 1.218 [95% CI: 1.138-1.303]) and lower body mass index (men, OR = 0.371 [95% CI: 0.299-0.461]; women, OR = 0.498 [95% CI: 0.419-0.593]) were independent risk factors for sarcopenia.
Although we confirmed that diabetes mellitus is associated with sarcopenia in both sexes, prediabetes is associated with sarcopenia in men, but not in women.
肌少症是老年人残疾的主要原因。虽然 2 型糖尿病是肌少症风险增加的一个因素,但前驱糖尿病与肌少症之间的关系尚未阐明。我们旨在研究肌少症与前驱糖尿病之间的关系。
本研究设计为横断面研究。我们在日本东京城区的 1629 名老年人中,使用 75g 口服葡萄糖耐量试验和糖化血红蛋白、四肢骨骼肌质量和握力评估葡萄糖代谢情况。我们调查了具有正常糖耐量(NGT)、前驱糖尿病和糖尿病的参与者中肌少症的发生率。使用多变量逻辑回归模型分析了葡萄糖耐量与肌少症患病率之间的关联。
参与者的平均年龄为 73.1±5.4 岁。在男性中,44.3%的人有 NGT,26.6%的人有前驱糖尿病,29.1%的人有糖尿病。在女性中,分布为 56.1%、28.8%和 15.2%。男性肌少症的患病率为 12.7%,女性为 11.9%。逻辑回归显示,前驱糖尿病和糖尿病是男性肌少症的独立危险因素(前驱糖尿病,OR=2.081[95%置信区间{CI}:1.031-4.199];糖尿病,OR=2.614[95%CI:1.362-5.018]),而糖尿病,而不是前驱糖尿病,是女性肌少症的独立危险因素(前驱糖尿病,OR=1.036[95%CI:0.611-1.757];糖尿病,OR=2.099[95%CI:1.146-3.844])。在两性中,年龄较大(男性,OR=1.086[95%CI:1.028-1.146];女性,OR=1.195[95%CI:1.142-1.251])、体脂百分比较高(男性,OR=1.346[95%CI:1.240-1.461];女性,OR=1.218[95%CI:1.138-1.303])和较低的体重指数(男性,OR=0.371[95%CI:0.299-0.461];女性,OR=0.498[95%CI:0.419-0.593])是肌少症的独立危险因素。
虽然我们证实糖尿病与两性的肌少症有关,但前驱糖尿病与男性的肌少症有关,而与女性无关。